Inducible Cold Urticaria

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-02-21
Clinical Trial Update: Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS) [Phase 3]
Phase 3 trial evaluating dupilumab for chronic inducible cold urticaria in patients not adequately controlled by H1 antihistamines has compl…